Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

U.S. Miner Announces $7B Acquisition of Co.

% of readers think this story is Fact. Add your two cents.


Source: Joe Reagor 11/06/2025

Coeur Mining Inc.’s (CDE:NYSE) pending takeout of New Gold Inc. (NGD:TSX; NGD:NYSE.MKT) is heavily focused on near-term metrics like free cash flow per share, noted a ROTH Capital Partners report.

Coeur Mining Inc. (CDE:NYSE) agreed to acquire New Gold Inc. (NGD:TSX; NGD:NYSE.MKT) in a US$7 billion all-stock transaction, reported Joe Reagor, managing director and senior research analyst at ROTH Capital Partners, in a November 4 research note. The deal is expected to close near the end of Q1/26.

“The acquisition appears accretive to near-term multiples, but both of New Gold’s mines have relatively short mine lives,” Reagor wrote. “The ultimate impact of the acquisition may be difficult to judge until many years from now.”

32% Return Implied

Because ROTH views this transaction as one strongly focused on the near term but with questions remaining about the long term, the investment banking firm maintained its Buy rating and US$20 per share target price on Coeur, noted the analyst.

In comparison, the Illinois-based gold and silver producer was priced at about US$15.14 per share at the time of Reagor’s report. From there, the return to target is 32%.

The company has 642.22 million shares outstanding. With the acquisition, New Gold shareholders are to receive 0.4959 of a Coeur share for every New Gold share.

Coeur’s market cap is US$11B. Its 52-week range is US$4.81–23.10 per share.

Near-Term-Focused Deal

Reagor pointed out similarities between the pending Coeur-New Gold acquisition and the past Coeur-SilverCrest Metals Inc. acquisition (February of this year). SilverCrest had one asset with a short mine life but with obvious expansion potential. New Gold has two assets, each with strong near-term production followed by periods of lower production, a relatively short mine life and significant potential for mine life extension. Despite the potential, the future of New Gold’s projects is unknown.

Also, the assets in both acquisitions were/are materially accretive with respect to near-term metrics like free cash flow per share, noted Reagor.

“Given the uncertainty of timing and shareholder approval required, we are excluding this [acquisition] from our forward estimates for now,” added the analyst.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. Doresa Banning wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor.
  2. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Disclosures for ROTH Capital Partners, Coeur Mining Inc., November 4, 2025

Regulation Analyst Certification (“Reg AC”): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Each box on the Rating and Price Target History chart above represents a date on which an analyst made a change to a rating or price target, except for the first box, which may only represent the first note written during the past three years. Distribution Ratings/IB Services shows the number of companies in each rating category from which Roth or an affiliate received compensation for investment banking services in the past 12 month. Distribution of IB Services Firmwide IB Serv./Past 12 Mos. as of November 3, 2025 Rating Count Percent Count Percent Buy [B] 361 75.37 99 27.42 Neutral [N] 83 17.33 6 7.23 Sell [S] 2 0.42 1 50.00 Under Review [UR] 33 6.89 8 24.24 Our rating system attempts to incorporate industry, company and/or overall market risk and volatility. Consequently, at any given point in time, our investment rating on a stock and its implied price movement may not correspond to the stated 12-month price target. Ratings System Definitions – ROTH Capital employs a rating system based on the following: Buy: A rating, which at the time it is instituted and or reiterated, that indicates an expectation of a total return of at least 10% over the next 12 months.

Neutral: A rating, which at the time it is instituted and or reiterated, that indicates an expectation of a total return between negative 10% and 10% over the next 12 months. Sell: A rating, which at the time it is instituted and or reiterated, that indicates an expectation that the price will depreciate by more than 10% over the next 12 months. Under Review [UR]: A rating, which at the time it is instituted and or reiterated, indicates the temporary removal of the prior rating, price target and estimates for the security. Prior rating, price target and estimates should no longer be relied upon for UR-rated securities. Not Covered [NC]: ROTH Capital does not publish research or have an opinion about this security. ROTH Capital Partners, LLC and its affiliates expects to receive or intends to seek compensation for investment banking or other business relationships with the covered companies mentioned in this report in the next three months. The material, information and facts discussed in this report other than the information regarding ROTH Capital Partners, LLC and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This report should not be used as a complete analysis of the company, industry or security discussed in the report. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in this report are subject to change without notice. An investment in the stock may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Additionally, an investment in the stock may involve a high degree of risk and may not be suitable for all investors. No part of this report may be reproduced in any form without the express written permission of ROTH. Copyright 2025. Member: FINRA/SIPC.

( Companies Mentioned: CDE:NYSE, )


Source: https://www.streetwisereports.com/article/2025/11/06/u-s-miner-announces-7b-acquisition-of-co.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login